Brickell Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BBI and buy or sell other stocks, ETFs, and their options commission-free!About BBI
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis.
CEOAlbert N. Marchio, II, MBA
CEOAlbert N. Marchio, II, MBA
Employees—
Employees—
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2009
Founded2009
Employees—
Employees—
BBI Key Statistics
Market cap5.59M
Market cap5.59M
Price-Earnings ratio-0.66
Price-Earnings ratio-0.66
Dividend yield—
Dividend yield—
Average volume1.79K
Average volume1.79K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.03
52 Week high$1.03
52 Week low$0.03
52 Week low$0.03
Stock Snapshot
The current Brickell Biotech(BBI) stock price is $4.03, with a market capitalization of 5.59M. The stock trades at a price-to-earnings (P/E) ratio of -0.66.
Brickell Biotech(BBI) stock opened on 2025-12-10 at —. The price climbed to — and dipped to —.
Brickell Biotech(BBI) shares are trading with a volume of 0, against a daily average of 1.79K.
In the last year, Brickell Biotech(BBI) shares hit a 52-week high of $1.03 and a 52-week low of $0.03.
In the last year, Brickell Biotech(BBI) shares hit a 52-week high of $1.03 and a 52-week low of $0.03.
People also own
Based on the portfolios of people who own BBI. This list is generated using Robinhood data, and it’s not a recommendation.